, Volume 176, Issue 3–4, pp 175–181 | Cite as

Impact of Eating Probiotic Yogurt on Colonization by Candida Species of the Oral and Vaginal Mucosa in HIV-Infected and HIV-Uninfected Women

  • Haihong Hu
  • Daniel J. MerensteinEmail author
  • Cuiwei Wang
  • Pilar R. Hamilton
  • Mandy L. Blackmon
  • Hui Chen
  • Richard A. Calderone
  • Dongmei Li



Candidiasis in HIV/AIDS patients continues to be a public health problem. Antifungal therapies are not always effective and may result in complications, such as the development of drug-resistant strains of Candida species.


This study evaluated the impact of probiotic consumption on Candida colonization of the oral and vaginal mucosa.


A pilot study was conducted in 24 women (17 HIV-infected, 7 HIV-uninfected) from the Women’s Interagency HIV Study. The women underwent a 60-day initiation period with no probiotic consumption, followed by two 15-day consumption periods, with a different probiotic yogurt (DanActive™ or YoPlus™ yogurt) during each interval. There was a 30-day washout period between the two yogurt consumption periods. Oral and vaginal culture swabs were collected on days 0, 60, 74, and 120. Candida was detected by inoculating each swab in both Sabouraud’s dextrose agar with or without chloramphenicol and CHROMagar.


Less fungal colonization among women was observed when the women consumed probiotic yogurts (54 % of the women had vaginal fungal colonization during the non-probiotic yogurt consumption period, 29 % during the DanActive™ period, and 38 % during YoPlus™ yogurt consumption period), and HIV-infected women had significantly lower vaginal fungal colonization after they consumed DanActive™ yogurt compared to the non-intervention periods (54 vs 29 %, p = 0.03).


These data are promising, but as expected in a small pilot study, there were some significant changes but also some areas where colonization was not changed. This type of conflicting data is supportive of the need for a larger trial to further elucidate the role of probiotic yogurts in fungal growth in HIV-infected women.


Probiotics Vulvovaginal candidiasis Oral candidiasis Candida HIV Opportunistic infections 



Data in this manuscript were collected by the Women’s Interagency HIV Study (WIHS) Collaborative Study Group. The WIHS is funded by the National Institute of Allergy and Infectious Diseases (U01-AI-35004, U01-AI-31834, U01-AI-34994, U01-AI-34989, U01-AI-34993, and U01-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. This publication was also made possible by The American Recovery and Reinvestment Act of 2009 Grant number 3U01AI034994-17S1R from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIAID.

Conflict of interest

D. Merenstein has served as a paid consultant to General Mills and Nestlé. The other authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.


  1. 1.
    Ohmit SE, Sobel JD, Schuman P, Duerr A, Mayer K, Rompalo A, et al. Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis. 2003;188(1):118–27. doi: 10.1086/375746.PubMedCrossRefGoogle Scholar
  2. 2.
    Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000;27(4):230–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Hauman CH, Thompson IO, Theunissen F, Wolfaardt P. Oral carriage of Candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol. 1993;76(5):570–2.PubMedCrossRefGoogle Scholar
  4. 4.
    Samaranayake LP. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol. 1992;73(2):171–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Sobel JD. Treatment of vaginal Candida infections. Expert Opin Pharmacother. 2002;3(8):1059–65. doi: 10.1517/14656566.3.8.1059.PubMedCrossRefGoogle Scholar
  6. 6.
    Guidelines for the Evaluation of probiotics in food. London, Ontario, Canada. 2002.Google Scholar
  7. 7.
    Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother. 2006;58(2):266–72. doi: 10.1093/jac/dkl246.PubMedCrossRefGoogle Scholar
  8. 8.
    Ehrstrom S, Daroczy K, Rylander E, Samuelsson C, Johannesson U, Anzen B, et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect. 2010;12(10):691–9. doi: 10.1016/j.micinf.2010.04.010.PubMedCrossRefGoogle Scholar
  9. 9.
    Martinez RC, Franceschini SA, Patta MC, Quintana SM, Candido RC, Ferreira JC, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009;48(3):269–74. doi: 10.1111/j.1472-765X.2008.02477.x.PubMedCrossRefGoogle Scholar
  10. 10.
    Zwolinska-Wcislo M, Brzozowski T, Mach T, Budak A, Trojanowska D, Konturek PC, et al. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol. 2006;57(Suppl 9):35–49.PubMedGoogle Scholar
  11. 11.
    Pirotta MV, Gunn JM, Chondros P. “Not thrush again!” Women’s experience of post-antibiotic vulvovaginitis. Med J Aust. 2003;179(1):43–6.PubMedGoogle Scholar
  12. 12.
    Osset J, Garcia E, Bartolome RM, Andreu A. Role of Lactobacillus as protector against vaginal candidiasis. Med Clin (Barc). 2001;117(8):285–8.CrossRefGoogle Scholar
  13. 13.
    Strus M, Brzychczy-Wloch M, Kucharska A, Gosiewski T, Heczko PB. Inhibitory activity of vaginal Lactobacillus bacteria on yeasts causing vulvovaginal candidiasis. Med Dosw Mikrobiol. 2005;57(1):7–17.PubMedGoogle Scholar
  14. 14.
    Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med. 1992;116(5):353–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876–83. doi: 10.1056/NEJMoa033114.PubMedCrossRefGoogle Scholar
  16. 16.
    Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, et al. The Women’s Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12(9):1013–9. doi: 10.1128/CDLI.12.9.1013-1019.2005.PubMedGoogle Scholar
  17. 17.
    Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The Women’s Interagency HIV Study. WIHS collaborative study group. Epidemiology. 1998;9(2):117–25.PubMedCrossRefGoogle Scholar
  18. 18.
    Powell HL, Sand CA, Rennie RP. Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species. Diagn Microbiol Infect Dis. 1998;32(3):201–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Ramani R, Gromadzki S, Pincus DH, Salkin IF, Chaturvedi V. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates. J Clin Microbiol. 1998;36(11):3396–8.PubMedGoogle Scholar
  20. 20.
    Barry AL, Pfaller MA, Rennie RP, Fuchs PC, Brown SD. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother. 2002;46(6):1781–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Graybill JR, Vazquez J, Darouiche RO, Morhart R, Greenspan D, Tuazon C, et al. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients. Am J Med. 1998;104(1):33–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Anukam KC, Osazuwa EO, Osadolor HB, Bruce AW, Reid G. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol. 2008;42(3):239–43. doi: 10.1097/MCG.0b013e31802c7465.PubMedGoogle Scholar
  23. 23.
    Irvine SL, Hummelen R, Hekmat S, Looman CW, Habbema JD, Reid G. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol. 2010;44(9):e201–5. doi: 10.1097/MCG.0b013e3181d8fba8.PubMedCrossRefGoogle Scholar
  24. 24.
    Reid G. The potential role for probiotic yogurt for people living with HIV/AIDS. Gut Microbes. 2010;1(6):411–4. doi: 10.4161/gmic.1.6.14079.PubMedCrossRefGoogle Scholar
  25. 25.
    Lloyd A. HIV infection and AIDS. P N G Med J. 1996;39(3):174–80.PubMedGoogle Scholar
  26. 26.
    Hummelen R, Changalucha J, Butamanya NL, Koyama TE, Cook A, Habbema JD, et al. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes. 2011;2(2):80–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Cassani E, Privitera G, Pezzoli G, Pusani C, Madio C, Iorio L, et al. Use of probiotics for the treatment of constipation in Parkinson’s disease patients. Minerva Gastroenterol Dietol. 2011;57(2):117–21.PubMedGoogle Scholar
  28. 28.
    Zaharoni H, Rimon E, Vardi H, Friger M, Bolotin A, Shahar DR. Probiotics improve bowel movements in hospitalized elderly patients–the PROAGE study. J Nutr Health Aging. 2011;15(3):215–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Haihong Hu
    • 1
  • Daniel J. Merenstein
    • 2
    Email author
  • Cuiwei Wang
    • 1
  • Pilar R. Hamilton
    • 1
  • Mandy L. Blackmon
    • 1
  • Hui Chen
    • 3
  • Richard A. Calderone
    • 3
  • Dongmei Li
    • 3
  1. 1.Department of MedicineGeorgetown University Medical CenterWashingtonUSA
  2. 2.Department of Family MedicineGeorgetown University Medical CenterWashingtonUSA
  3. 3.Department of Microbiology and ImmunologyGeorgetown University Medical CenterWashingtonUSA

Personalised recommendations